Oseltamivir Phosphate For Oral Suspension Powder, For Suspension
Product Images NDC 72516-029

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate For Oral Suspension (NDC 72516-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This is a detailed medication label for Oseltamivir Phosphate oral suspension, providing information on dosage, storage instructions, and preparation steps. It includes details on the recommended storage temperatures for both the dry powder and constituted suspension, as well as guidance for pharmacists on preparing the suspension at the time of dispensing. The text also emphasizes the importance of shaking the product before each use and provides directions for patients and caregivers on storing and discarding unused portions. Additionally, it mentions the manufacturer, Oryza Pharmaceuticals, Inc., and the concentration of Oseltamivir base in the suspension.*

FDA Label Image

Label (Label)

This text provides important instructions for preparing and using an oral suspension containing 6 mg of oseltamivir base per mL. It includes details like shaking well before use, how to constitute the oral suspension, storage instructions, dosage guidelines, and expiration dates. The product is to be prepared by a pharmacist at the time of dispensing. The information also mentions the manufacturer as Oryza Pharmaceuticals, Inc. from Coral Springs, FL.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.